髓系分化因子88,Myeloid differentiation factor 88,在线英语词典,英文翻译,专业英语

1) Myeloid differentiation factor 88

髓系分化因子88

[Objective]To clarify the expression changes of Myeloid differentiation factor 88(MyD88)and Nuclear factor-κB(NF-κB)in pancreatic tissues of mice with acute pancreatitis(AP)and their relationship with AP.

[目的]分析急性胰腺炎(AP)小鼠胰腺组织中髓系分化因子88(MyD88)和核因子-κB(NF-κB)的表达变化及其与AP之间的关系。

2) myeloid

髓系

Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia;

141例儿童急性髓系白血病的疗效及预后相关因素分析

Gene expression profile associated with prognosis in acute myeloid leukemia;

急性髓系白血病预后相关基因表达谱

Chemotherapy with CAG regimen to patients with hypoplastic acute myeloid leukemia;

CAG方案治疗低增生性急性髓系白血病临床分析

3) Myelogenous

髓系

Analysis of telomerase activity and telomere length in acute myelogenous leukemia;

急性髓系白血病细胞端粒酶活性及端粒长度的同步分析

4) myeloid antigen

髓系抗原

To explore the complexity of the pathogenesis and pathology of BMN and understand the multiplicity of clinical features, a case of Philadelphia chromosome positive (Ph+) B acute lymphoblastic leukemia (ALL) expressing myeloid antigens was reported.

为加强对骨髓坏死(BMN)的病因及病理过程复杂性的认识,了解髓系抗原阳性(My+)及Ph染色体阳性(Ph+)的B急性淋巴细胞白血病(ALL)临床表现的多样性,报道分析了1例以BMN为首发症状的My+Ph+B-ALL并进行讨论。

Results In whole ALL,the expression of myeloid antigens occurred in 64 % of the cases,and the expression frequency had no significant tendency in T and B subtypes.

结果在ALL中,髓系抗原(M)表达64%,T和B亚型中髓系抗原表达差异无显著性意义(P>0。

The study was aimed to explore the chemokine receptor CXCR4 expression on the B-lineage acute lymphocyte leukemia (B-ALL) cells of various differentiation stages and its relationship with myeloid antigen expression.

本研究目的是探讨趋化因子受体CXCR4在急性B淋巴细胞白血病 (B ALL)细胞不同分化阶段的表达特点及其与髓系抗原的关系。

5) acute myeloid

急性髓系

Clinical significance of survivin, multidrug resistance and lung resistance protein gene expression in acute myeloid leukemia;

急性髓系白血病生存素、多药耐药基因与肺耐药基因的表达及其临床意义

6) myeloid cells

髓系细胞

Purpose To examine whether BST?1/CD157 expressed on myeloid cells can function as a receptor molecule to mediate signal into cells and regulate the expression of FcγR on cells.

目的　探讨髓系细胞表面BST 1(骨髓基质细胞抗原 1) /CD15 7分子能否作为一受体介导信号传导和调节细胞表面FcγR的表达。

参考词条

髓系培养体系慢性髓系白血病髓系抗原阳性恶性髓系血液病髓系-NK起始细胞肌肉骨髓系统髓系相关抗原髓系过氧化物酶急性白血病/髓系髓系白血病细胞髓系恶性血液病松脂醇二葡糖苷充压真空法

补充资料：正常人白细胞转移因子 , 白细胞转移因子,转移因子

药物名称：转移因子

英文名：Transfer Factor

别名： 正常人白细胞转移因子 , 白细胞转移因子,转移因子
外文名：Transfer Factor ,TF
适应症： 为细胞免疫反应增强剂，能将细胞免疫活性转移给受体，以提高受体的免疫功能。
临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染（如带状皰疹、流行性乙型脑炎、白色念珠菌感染等）。对恶性肿瘤可作为辅助治疗剂，对自体免疫性疾病也有一定治疗作用。
用量用法：
一般采用皮下注射，注于上臂内侧或大腿内侧腹股沟下端，１次注射１支，每周１～２次，１个月后改为每２周１次。对带状疱疹，一般只需注射１次。
规格： 注射液：每支２ｍｌ，相当于１×１０００００００００白细胞提取物（上海产）,北京产则相当于５～１０×1000000000.
注：严禁静脉给药.

类别：免疫调节剂

说明：补充资料仅用于学习参考，请勿用于其它任何用途。

首页 \| 翻译 \| 影视 \| 论坛 \| 索引髓系肿瘤髓系肉瘤髓系祖细胞髓系白血病急性髓系白血病

1) Myeloid differentiation factor 88 髓系分化因子88 1. [Objective]To clarify the expression changes of Myeloid differentiation factor 88(MyD88)and Nuclear factor-κB(NF-κB)in pancreatic tissues of mice with acute pancreatitis(AP)and their relationship with AP. [目的]分析急性胰腺炎(AP)小鼠胰腺组织中髓系分化因子88(MyD88)和核因子-κB(NF-κB)的表达变化及其与AP之间的关系。 2) myeloid 髓系 1. Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia; 141例儿童急性髓系白血病的疗效及预后相关因素分析 2. Gene expression profile associated with prognosis in acute myeloid leukemia; 急性髓系白血病预后相关基因表达谱 3. Chemotherapy with CAG regimen to patients with hypoplastic acute myeloid leukemia; CAG方案治疗低增生性急性髓系白血病临床分析 3) Myelogenous 髓系 1. Analysis of telomerase activity and telomere length in acute myelogenous leukemia; 急性髓系白血病细胞端粒酶活性及端粒长度的同步分析 4) myeloid antigen 髓系抗原 1. To explore the complexity of the pathogenesis and pathology of BMN and understand the multiplicity of clinical features, a case of Philadelphia chromosome positive (Ph+) B acute lymphoblastic leukemia (ALL) expressing myeloid antigens was reported. 为加强对骨髓坏死(BMN)的病因及病理过程复杂性的认识,了解髓系抗原阳性(My+)及Ph染色体阳性(Ph+)的B急性淋巴细胞白血病(ALL)临床表现的多样性,报道分析了1例以BMN为首发症状的My+Ph+B-ALL并进行讨论。 2. Results In whole ALL,the expression of myeloid antigens occurred in 64 % of the cases,and the expression frequency had no significant tendency in T and B subtypes. 结果在ALL中,髓系抗原(M)表达64%,T和B亚型中髓系抗原表达差异无显著性意义(P>0。 3. The study was aimed to explore the chemokine receptor CXCR4 expression on the B-lineage acute lymphocyte leukemia (B-ALL) cells of various differentiation stages and its relationship with myeloid antigen expression. 本研究目的是探讨趋化因子受体CXCR4在急性B淋巴细胞白血病 (B ALL)细胞不同分化阶段的表达特点及其与髓系抗原的关系。 5) acute myeloid 急性髓系 1. Clinical significance of survivin, multidrug resistance and lung resistance protein gene expression in acute myeloid leukemia; 急性髓系白血病生存素、多药耐药基因与肺耐药基因的表达及其临床意义 6) myeloid cells 髓系细胞 1. Purpose To examine whether BST?1/CD157 expressed on myeloid cells can function as a receptor molecule to mediate signal into cells and regulate the expression of FcγR on cells. 目的　探讨髓系细胞表面BST 1(骨髓基质细胞抗原 1) /CD15 7分子能否作为一受体介导信号传导和调节细胞表面FcγR的表达。参考词条髓系培养体系慢性髓系白血病髓系抗原阳性恶性髓系血液病髓系-NK起始细胞肌肉骨髓系统髓系相关抗原髓系过氧化物酶急性白血病/髓系髓系白血病细胞髓系恶性血液病松脂醇二葡糖苷充压真空法补充资料：正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称：转移因子英文名：Transfer Factor 别名：正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名：Transfer Factor ,TF 适应症：为细胞免疫反应增强剂，能将细胞免疫活性转移给受体，以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染（如带状皰疹、流行性乙型脑炎、白色念珠菌感染等）。对恶性肿瘤可作为辅助治疗剂，对自体免疫性疾病也有一定治疗作用。用量用法：一般采用皮下注射，注于上臂内侧或大腿内侧腹股沟下端，１次注射１支，每周１～２次，１个月后改为每２周１次。对带状疱疹，一般只需注射１次。规格：注射液：每支２ｍｌ，相当于１×１０００００００００白细胞提取物（上海产）,北京产则相当于５～１０×1000000000. 注：严禁静脉给药. 类别：免疫调节剂说明：补充资料仅用于学习参考，请勿用于其它任何用途。
©2008 dictall.com